News
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
1mon
GlobalData on MSNFDA authorises ImmunityBio’s BCG alternative to treat bladder cancerImmunityBio founder, executive chairman and global chief scientific ... with the Serum Institute of India to obtain a supply ...
Supply shortages of TICE BCG in the U.S. have become a significant ... Founder, Executive Chairman and Global Chief Scientific and Medical Officer of ImmunityBio. “Participation by a major ...
Christoph Schweizer was elected BCG’s CEO in May 2021. Prior to this role, he was BCG’s chairman for Central and Eastern Europe and the Middle East. He has also served as a member of the firm ...
Altice USA (NYSE: ATUS) is one of the largest broadband communications and video services providers in the United States, delivering broadband, video, mobile, proprietary content and advertising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results